Marek Michalak

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 8 CIPO patents and 3 EPO patents. Top assignees: New York University, Calregen Inc., Calretex LLC. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marek Michalak. Retrieved from https://idiyas.com/inventor/marek-michalak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 87.5

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Edmonton, CA (US) (2016)
Edmonton, CA (2012 - 2023)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11723954 - Therapeutic and cosmetic uses and applications of calreticulin (2023-08-15),

2. 11045521 - Therapeutic and cosmetic uses and applications of calreticulin (2021-06-29),

3. 10314888 - Therapeutic and cosmetic uses and applications of calreticulin (2019-06-11),

4. 9796971 - Generation of native recombinant secreted human endoplasmic reticulum chaperones by using their native signal sequences in yeast expression systems (2017-10-24),

5. 9254310 - Therapeutic and cosmetic uses and applications of calreticulin (2016-02-09),

6. 9095550 - Methods for treating diabetic wounds (2015-08-04),

7. 8399631 - Compositions and methods for purifying calreticulin (2013-03-19),

8. 8129341 - Methods for treating diabetic wounds (2012-03-06),

Title: The Innovative Contributions of Marek Michalak

Introduction

Marek Michalak is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of therapeutic and cosmetic applications, holding a total of 8 patents. His work focuses on the innovative uses of calreticulin, a protein that plays a crucial role in various biological processes.

Latest Patents

Marek's latest patents revolve around the therapeutic and cosmetic uses of calreticulin. These inventions include methods for reducing and eliminating wrinkles and fine lines, tissue repair and reconstruction, and repairing damaged cartilage. Additionally, his patents address stimulating the regeneration of epidermal appendages, enhancing phagocytosis of bacteria by phagocytes within wounds, treating wounds in patients with delayed healing, and preventing surgical adhesions.

Career Highlights

Throughout his career, Marek has worked with prestigious institutions such as New York University and Calregen Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in therapeutic and cosmetic applications.

Collaborations

Marek has collaborated with notable individuals in his field, including Leslie I Gold and Kestutis Sasnauskas. These partnerships have further enriched his research and development efforts.

Conclusion

Marek Michalak's contributions to the field of therapeutic and cosmetic applications through his innovative use of calreticulin highlight his role as a significant inventor. His work continues to impact the industry positively, showcasing the importance of innovation in improving health and beauty solutions.

Profile summary based on public USPTO records.